부가기능
Differences in Estrogen Receptor Status, HER2, and p53 Comparing Metachronous Bilateral Breast Carcinoma - p53 and HER2 expression levels in the second tumors might be the same as those of the first tumors in metachronous bilateral breast carcinoma; however, loss of ER was more frequently observed in the second primary tumors than in the first tumors./
기사 상세정보
서평
서평등록 중 오류가 발생하였습니다. 재시도 하십시오.